American Diabetes Association Issues Updates to Standards of Care in Diabetes for 2025
Drug Topics
APRIL 21, 2025
The authors emphasize the importance of multifaceted and team-based approaches to the management of diabetes.
Mon.Apr 21, 2025
447 
Intensive lowering of blood pressure tied to lower dementia risk
STAT
APRIL 21, 2025
High blood pressure earned its reputation as the silent killer by causing heart attacks, heart failure, and strokes. It’s also been a suspect in dementia. Some studies have hinted at a correlation between lower blood pressure and fewer dementia cases, but they were too small and too short to lend statistical significance to the link. It’s also been noted that people with untreated high blood pressure carry a 42% higher risk of developing dementia.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Orforglipron Shows Superior Reduction in Hemoglobin A1c for Patients With Type 2 Diabetes
Drug Topics
APRIL 21, 2025
Investigators find that orforglipron lowered A1c by an average of 1.3% to 1.6% from a baseline of 8% across 3 different dosages.
FDA approves novel therapy for chronic skin condition
European Pharmaceutical Review
APRIL 21, 2025
For the first time in over ten years, the US Food and Drug Administration (FDA) has approved a new targeted treatment for chronic spontaneous urticaria. Sanofi and Regeneron Pharmaceuticals collaborated to develop Dupixent (dupilumab). Under the FDA’s new authorisation, the therapy is indicated for individuals aged 12 years and over with the chronic inflammatory skin disease, who still experience symptoms despite taking histamine-1 (H1) antihistamine medication.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
The Importance of Pharmacists in OTC Counseling Amid Opioid Crisis
Drug Topics
APRIL 21, 2025
Mark Garofoli, PharmD, MBA, BCGP, CPE, CTTS, discusses trends in over-the-counter pain medications amid the ongoing opioid emergency in the US.
Opinion: Physician groups need to become better advocates
STAT
APRIL 21, 2025
Democrats recently unveiled a campaign to recruit and elect 100 doctors to public office. Democrats hope that by recruiting physicians to public office, they will be able to combat misinformation and restore trust in medicine and science. Amid a full-blown measles outbreak, the U.S. plan to withdraw from the World Health Organization, the confirmation of Robert F.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
The NIH puts a further chokehold on universities, and Ireland braces for pharma tariffs
STAT
APRIL 21, 2025
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning, Jason Mast here filling in for Theresa. The Morning Rounds editor has informed me that she has tired of all this debate over potato chips and the curious case of the vanishing sour cream and onion. Therefore, I will move on to french fries.
How a scrapped Pfizer drug became a winner for SpringWorks
PharmaVoice
APRIL 21, 2025
SpringWorks Therapeutics and the Children’s Tumor Foundation salvaged a shelved asset for neurofibromatosis and got it over the regulatory finish line.
STAT+: Immunovant replaces CEO, makes other changes as Roivant tightens control
STAT
APRIL 21, 2025
Immunovant on Monday announced changes to its management team, including the naming of a new chief executive, intended to give its majority owner, Roivant Sciences, greater control over the biotech company’s operations. Pete Salzmann, Immunovant’s current CEO and board member, is retiring. He will be replaced by Eric Venker, Roivant’s current president and chief operating officer.
Reports Document FDA Review Delays: What Drugmakers Should Know Now
The FDA Law Blog
APRIL 21, 2025
By John W.M. Claud & Michelle L. Butler Recent reductions in force (RIFs) and leadership changes at FDA are already affecting key agency functionsand as the administration plans a broader reorganization, the impact will likely grow. One area drawing increasing attention is how these changes will affect the drug development and review process. As reported by the Wall Street Journal last week , reviews of both innovative and follow-on drugs have been caught in a traffic jam, largely due to a
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
FDA approves blockbuster Dupixent for chronic hives
STAT
APRIL 21, 2025
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning. Today, we talk lots about tariffs — how they might impact drugmakers, patients, and even Ireland. Also, Novo Nordisk challenges Medicare over drug differentiation, and more.
How long does Symbicort stay in your system?
The Checkup by Singlecare
APRIL 21, 2025
Symbicort is a drug that healthcare professionals prescribe to treat asthma and chronic obstructive pulmonary disease (COPD). It contains two active ingredients: budesonide and formoterol fumarate dihydrate. Budesonide is a long-acting inhaled corticosteroid that helps relieve inflammation in the lungs and airways, while formoterol is a long-acting beta-2 agonist (LABA) that helps keep the airways open (a bronchodilator) by relaxing the smooth muscles around them.
QbD for biopharmaceutical product lifecycle management
European Pharmaceutical Review
APRIL 21, 2025
Quality-by-design (QbD) is a systemic risk-management strategy that facilitates the production of safe and consistent drugs. As pharma and biotech companies move towards more complex medicines, it is critical they have contract development and manufacturing organisation (CDMO) partners who can implement QbD principles while maintaining the accelerated timelines required for competitive business.
Email Marketing Campaigns: A Valuable Tactic in Pharma Marketing
Pharma Marketing Network
APRIL 21, 2025
Introduction In the ever-evolving world of healthcare promotion, pharma brands are constantly seeking reliable, cost-effective, and targeted strategies to stay connected with healthcare professionals (HCPs) and patients. Enter email marketing campaigns a digital tactic that’s proving to be more than just effective. But are these campaigns truly worth the investment in 2025’s competitive and compliance-heavy landscape?
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Antibiotic Use in Infants and Young Children May Increase Risk of Allergic Conditions
Pharmacy Times
APRIL 21, 2025
Children who received antibiotics between birth and 2 years of age were more likely to develop food allergies, allergic rhinitis, and asthma, but not neurodevelopmental conditions.
Fierce Healthcare - Untitled Article
Fierce Healthcare
APRIL 21, 2025
The study proves the effectiveness of delivering mental health therapy through a generative AI chatbot for the first time. The additional empathy and personalization of automated technology could spur adherence to software-based therapies, the study authors said.
Oral Colchicine Receives FDA Orphan Drug Designation for Pericarditis
Pharmacy Times
APRIL 21, 2025
An oral dose of 0.6 mg per 5 ml of colchicine could aid individuals that have trouble with swallowing pills.
Sanofi's Dupixent gets FDA nod for chronic hives indication
pharmaphorum
APRIL 21, 2025
Sanofi's Dupixent gets FDA nod for chronic hives indication Jonah.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Analysis Reveals Polypharmacy Challenges in Patients With Cancer
Pharmacy Times
APRIL 21, 2025
Although most health care professionals agree that patients do not need prescriptions for chronic diseases during end-of-life care, patients often receive them anyway.
Fierce Healthcare - Untitled Article
Fierce Healthcare
APRIL 21, 2025
Chapter, a Medicare navigation and advisory firm, picked up $75 million to build out its technology and new products and ink more partnerships with health systems.
Enhertu poised to move first line in HER2+ breast cancer
pharmaphorum
APRIL 21, 2025
New data could make HER2-directed antibody-drug conjugate (ADC) Enhertu an option for previously untreated breast cancer for the first time
Fierce Healthcare - Untitled Article
Fierce Healthcare
APRIL 21, 2025
Arkansas Gov. Sarah Huckabee Sanders signed a law barring pharmacy benefit managers operating in the state from owning pharmacies.
FDA Grants Breakthrough Therapy Designation to AMT-130 to Treat Huntington Disease
Pharmacy Times
APRIL 21, 2025
The breakthrough designation is supported by clinical data from ongoing phase 1/2 trials.
FDA grants breakthrough status to uniQure’s Huntington’s disease therapy
Pharmaceutical Technology
APRIL 21, 2025
The US Food and Drug Administration (FDA) has awarded breakthrough therapy designation to uniQure's AMT-130 for Huntington's disease.
Fierce Healthcare - Untitled Article
Fierce Healthcare
APRIL 21, 2025
Startup Brellium scored $16.7 million in series A funding to scale up its artificial intelligence-powered solution that helps providers automate clinical quality and payer compliance.
Trodelvy-Keytruda pairing hits the spot in breast cancer
pharmaphorum
APRIL 21, 2025
Gilead Sciences has cemented the role of its TROP2 drug Trodelvy in triple-negative breast cancer with a study win in combination with MSD's Keytruda.
Training and Education Ensure Safe Handling of Hazardous Drugs
Pharmacy Times
APRIL 21, 2025
By implementing work practices alongside administrative and engineering controls, a safe and healthy work environment can be achieved.
Fierce Healthcare - Untitled Article
Fierce Healthcare
APRIL 21, 2025
And Pacify, a doula-led maternal health solution, is partnering with Seven Starlings to offer specialized mental health care to its patients.
NCPA Report Outlines Potential Negative Impacts of MDPNP, Solutions
Pharmacy Times
APRIL 21, 2025
Ronna Hauser, PharmD, senior vice president of policy and pharmacy affairs at NCPA, discusses concerns about the implementation of the MDPNP.
Thermo Fisher Scientific Unveils Advanced Therapies Collaboration Center
Pharmaceutical Commerce
APRIL 21, 2025
The Carlsbad plant is expected to accelerate both the development and commercialization of cell therapies.
FAERS Analysis Provides New Insights on Cefiderocol Adverse Effects
Pharmacy Times
APRIL 21, 2025
In contrast to the study findings, the prescribing information for cefiderocol lists different common adverse effects.
UK’s MHRA authorises GSK’s Blenrep for multiple myeloma treatment
Pharmaceutical Technology
APRIL 21, 2025
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has authorised GSKs Blenrep for treating multiple myeloma (MM).
Fierce Healthcare - Untitled Article
Fierce Healthcare
APRIL 21, 2025
Legal experts agree the government should feel confident leaving oral arguments for a case deciding the fate of cost-free preventive services covered under the Affordable Care Act, with justices seemingly leaning toward protecting the task force. A decision is expected in June.
Let's personalize your content